Source: Eur Respir J, 55 (1) 1902204; 10.1183/13993003.02204-2019
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Michael R. Loebinger, Surinder S. Birring. Patient reported outcomes for non-tuberculous mycobacterial disease. Eur Respir J, 55 (1) 1902204; 10.1183/13993003.02204-2019

Member's Comments

No comment yet.

Related content which might interest you: The impact of new ATS/IDSA guideline for nontuberculous mycobacterial disease on the diagnosis of nontuberculous mycobacterial lung disease in Korea Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008 Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients Source: Eur Respir J 2006; 28: 1211-1215 Year: 2006 Cure rates in nontuberculous mycobacterial pulmonary disease Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019 Nontuberculous mycobacteria in bronchiectasis: prevalence and patient characteristics Source: Eur Respir J 2006; 28: 1204-1210 Year: 2006 Preliminary validation of the NTM Module: a patient-reported outcome measure for patients with pulmonary nontuberculous mycobacterial disease Source: Eur Respir J, 55 (1) 1901300; 10.1183/13993003.01300-2019 Year: 2020 Nontuberculous mycobacteria in non-HIV patients: epidemiology, treatment and response Source: Eur Respir J 2004; 23: 741-746 Year: 2004 Outcomes of patients undergoing treatment for non-tuberculous mycobacteria lung disease Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection Year: 2019 Pulmonary diseases due to non-tuberculous mycobacteria in TB referral clinical center Source: Annual Congress 2011 - Clinical challenges in tuberculosis Year: 2011 Clinical outcome of multiple nontuberculous mycobacteria infection among people with bronchiectasis in Taiwan: a cohort study Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria Year: 2020 Management of pulmonary nontuberculous mycobacteria disease Source: Eur Respir Monogr 2018; 81: 222-237 Year: 2018 Treatment outcomes of non tuberculous mycobacterial (NTM) pulmonary disease. Multicenter study Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection Year: 2020 Similar characteristics of nontuberculous mycobacterial pulmonary disease in men and women Source: Eur Respir J, 54 (1) 1900252; 10.1183/13993003.00252-2019 Year: 2019 When is an infectious disease? The clinical spectrum of nontuberculous mycobacterial pulmonary disease Source: International Congress 2019 – New guidelines for treatment of nontuberculous mycobacterial pulmonary disease Year: 2019 What is important for people with nontuberculous mycobacterial disease? An EMBARC-ELF patient survey Source: ERJ Open Res, 7 (1) 00807-2020; 10.1183/23120541.00807-2020 Year: 2021 Long-term follow-up study of patients with pneumoconiosis complicated by nontuberculous mycobacterial lung disease: report of four cases Source: Eur Respir J 2001; 18: Suppl. 33, 443s Year: 2001 Evaluating the non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis Source: Eur Respir J 2010; 35: 338-342 Year: 2010 Aero-environmental bacteriological survey of respiratory non-tuberculosis mycobacterial disease patients Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016 Clinical features and prognosis of nontuberculous mycobacterial pleuritis Source: International Congress 2019 – Pleural infection and complicated pneumonia Year: 2019